JAMA: Effect of continuous blood glucose monitoring on blood glucose control in adolescents with type I diabetes

Statistics found that adolescents and young people with type Idiabeteshad poor blood sugar control effect, and researchers recently examined the effects of continuous blood glucose monitoring (CGM) on blood sugar control in adolescents with type I diabetes153 people with type I diabetes between the ages of 14 and 24 were involved in the study, with hemoglobin A1c (HbA1c) levels of 7.5% to 10.9%, and were randomly treated with routine care for CGM (CGM group; n-74) and for blood glucose monitoring using a blood glucose meter (BGM group; n-79)The main results were changes from baseline to 26 weeks of HbA1c, and secondary results included additional glycated hemoglobin results, CGM blood glucose indicators, and patient-reported resultsThe average age ofpatients was 17 years, 50% were female, the average duration of diabetes was 9 years, and 142 (93%) patients completed the studyIn the CGM group, 68 percent of the participants used at least 5 days of CGM per week for six monthsThe average HbA1c for the CGM group was 8.9 per cent at the baseline and 8.5 per cent at 26 weeks, compared with 8.9 per cent at the baseline and at 26 weeks for the BGM group (the difference between groups was -0.37 per cent)Of the 20 pre-specified secondary results, there were statistical differences in 3 out of 7 HbA1c results, 8 out of 9 CGM indicators and 1 in 4 patientsThe most commonly reported adverse events in the CGM group and BGM group were severelow blood sugar(3 cases in the CGM group and 2 cases in the BGM group), hyperglycemia/ketosis (1 case in The CGM group and 4 cases in the BGM group), and diabetic ketoacidosis (3 cases in The CGM group, 1 case in BGM group)studies have shown that continuous blood glucose monitoring has some effect on the blood glucose control of type I diabetic patients compared with standard blood glucose monitoring